Scinai Immunotherapeutics Ltd. (SCNI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Scinai Immunotherapeutics...

NASDAQ: SCNI · Real-Time Price · USD
1.69
0.16 (10.10%)
At close: Aug 21, 2025, 2:50 PM

Scinai Immunotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.24M 658K 452K 284K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
1.24M 1.24M 865K 448K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-580K -580K -413K -164K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-1.93M -2.78M -2.34M -2.02M 2.99M 1.86M 8M 11.19M -1.04M -471K 2.88M -750K -217K 378K -11.08M -14.34M -16.26M
Interest Income
14.77M 14.76M 14.76M 5.19M 5.19M 5.19M 5.19M 1.78M 2.25M 2.62M 3.55M 2.38M 1.92M 1.91M 982.61K 370.57K 370.57K
Pretax Income
5.93M 3.77M 3.64M -3.7M -5.14M -6.5M -4.7M -6.75M -5.98M -4.94M -3.22M -7.07M -7.77M -7.74M -13.32M 5.63M -2.8M
Net Income
4.35M 3.74M 3.64M -3.7M -5.14M -6.5M -4.7M -6.75M -5.98M -4.94M -3.22M -7.07M -7.77M -7.74M -13.32M 5.63M -2.8M
Selling & General & Admin
2.54M 2.53M 2.9M 3.1M 3.73M 4.43M 5.11M 5.08M 5.23M 5.49M 5.77M 6.76M 7.62M 7.36M 6.6M 6.8M 5.85M
Research & Development
5.25M 5.54M 4.83M 4.56M 4.8M 5.21M 6.33M 6.31M 6.83M 6.21M 5.57M 5.08M 3.68M 3.13M 4.48M 7.53M 10.39M
Other Expenses
572K 448K 439K 439K -11.68M -11.55M -19.42M -22.56M -11.02M -11.23M -14.22M -11.08M -11.08M -10.87M 312.00 -22.03M -22.03M
Operating Expenses
1.94M 2.08M 1.8M 1.73M -3.11M -1.86M -8M -11.19M 1.04M 471K -2.88M 750K 217K -378K 11.08M -7.71M -5.79M
Interest Expense
2.23M 2.45M 2.92M 1.04M 1.9M 1.99M 1.48M 3.29M 2.33M 2.24M 3.1M 2.16M 2.81M 3.36M 2.73M 1.95M 5.27M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
-401K 3.44M 2.79M 2.31M -2.99M -1.86M -8M -11.19M 1.04M 471K -2.88M 750K 217K -378K 11.08M -7.71M -5.79M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
806.37K 392.23K 843.57K 637.6K 506.54K 223.32K 469.22K 337.96K 292.92K 194.35K 186.79K 186.72K 186.18K 75.06K 113.07K 143.3K 132.71K
Shares Outstanding (Diluted)
806.37K 1.24M 843.57K 637.6K 506.54K 300.38K 469.22K 337.96K 323.81K 194.35K 186.79K 186.72K 186.18K 145.15K 143.3K 143.3K 132.71K
EPS (Basic)
12.24K -4.8K -13.08K -36.16K -66.12K -92.48K -72.32K -76.28K -95.68K -105.44K -61.76K -162.6K -201.36K -222K -407.04K 231.6K -112.88K
EPS (Diluted)
12.24K -4.8K -23.76K -46.84K -76.8K -107.76K -112.84K -116.8K -136.2K -141.36K -158K -279.76K -318.52K -339.16K -431.32K 134.92K -209.56K
EBITDA
6.59M 6.02M 5.94M -7M -7.92M -9.19M -14.05M -10.79M -11.46M -10.89M -7.36M -11.03M -10.45M -9.81M -10.4M 8.37M 6.45M
EBIT
6.86M 6.12M 6.56M -7.88M -8.45M -9.71M -14.62M -11.44M -12.1M -11.53M -7.98M -11.61M -11.08M -10.48M -11.08M 7.71M 5.79M
Depreciation & Amortization
1.49M 1.65M 1.23M 881K 530.33K 512.33K 568.83K 642.01K 641.68K 637.68K 685.5K 657.14K 697.29K 748.13K 741.67K 734.57K 723.44K